SCHEMBL3449294

SCHEMBL3449294

CC(C)(C)OC(=O)N1CCC(CNC(=O)c2cc3cc(Cl)ccc3s2)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 2/20 0.54
KDM4E B2RXH2 1/20 0.50
PKM P14618 1/20 0.50
NAMPT P43490 2/20 0.49
CYP2C9 P11712 1/20 0.49
CHRNA7 P36544 2/20 0.46
HTR3A P46098 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPK8 P45983 2/20 0.43
NR1D1 P20393 1/20 0.43
UTS2R Q9UKP6 1/20 0.42
CCNT1 O60563 1/20 0.42
CDK9 P50750 1/20 0.42
GNRHR P30968 1/20 0.41
IL1B P01584 1/20 0.41
P2RX7 Q99572 1/20 0.41
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4592249 1.00 ACKR3 (0.54) ACKR3KDM4EPKMNAMPTCYP2C9
SCHEMBL3449291 1.00 ACKR3 (0.54) ACKR3KDM4EPKMNAMPTCYP2C9
SCHEMBL3447766 0.93 ACKR3 (0.54) ACKR3KDM4EPKMNAMPTCYP2C9
SCHEMBL3447771 0.93 ACKR3 (0.54) ACKR3KDM4EPKMNAMPTCYP2C9
SCHEMBL13126312 0.86 CHRNA7 (0.46) ACKR3CHRNA7HTR3AKMT2AUTS2R
SCHEMBL4592240 0.86 CHRNA7 (0.51) NAMPTCHRNA7HTR3AKMT2AUTS2R
SCHEMBL3449327 0.82 ACKR3 (0.65) ACKR3KDM4EPKMNAMPTMEN1
SCHEMBL3449326 0.82 ACKR3 (0.65) ACKR3KDM4EPKMNAMPTMEN1
SCHEMBL3450135 0.81 NAMPT (0.51) ACKR3KDM4EPKMNAMPTMEN1
SCHEMBL3450134 0.81 NAMPT (0.51) ACKR3KDM4EPKMNAMPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820699-B2 Cyclic amines HOFFMANN-LA ROCHE INC. (US) 2010-10-26 US disclosed
US-20060247238-A1 Cyclic amines F. HOFFMANN-LA ROCHE AG (CH) 2006-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060247238-A1 Cyclic amines F12, F11, F2 ACKR3 568/4885KDM4E 2242/4885PKM 1858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.